CERo Therapeutics (NASDAQ:CERO) Coverage Initiated at D. Boral Capital
Analysts at D. Boral Capital initiated coverage on shares of CERo Therapeutics (NASDAQ:CERO – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $11.00 price target on the stock. CERo Therapeutics Price Performance Shares of NASDAQ:CERO opened at $0.80 on Tuesday. CERo Therapeutics has […]
Analysts at D. Boral Capital initiated coverage on shares of CERo Therapeutics (NASDAQ:CERO – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $11.00 price target on the stock. CERo Therapeutics Price Performance Shares of NASDAQ:CERO opened at $0.80 on Tuesday. CERo Therapeutics has […]